Industry reports
Editor highlights

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics, March 2014 (p40)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

1171-1220 of about 30 000 reports
France Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

France Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Despite concerted progress made on the fiscal consolidation front in the first half of 2011, the French government’s medium-term fiscal targets remain on the optimistic side, particularly given ...

  • Industries : Prescription Drug
  • Countries : France
Peru Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Peru Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Peru’s large and growing population underpins the potential of its pharmaceutical industry , especially given the rising prevalence of non-communicable diseases. However, Peru remains listed ...

  • Industries : Pharmaceutical
  • Countries : Peru
Singapore Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Singapore Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Singapore is a well-developed pharmaceutical industry, although overall revenues only reached a modest SGD901mn (US Dollar 716mn) in 2011, on account of the small population of the city-state. ...

  • Industries : Drug and Medication
  • Countries : Singapore
Kazakhstan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Kazakhstan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Kazakhstan remains the most accessible and competitive pharmaceutical industry in Central Asia and the growing expectation it will gain World Trade Organisation (WTO) membership by the end of ...

  • Industries : Drug and Medication
  • Countries : Kazakhstan
United States Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

United States Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Economics and politics are increasingly exerting an influence on the US pharmaceutical market. This is in stark contrast to the late 1990s and early 2000s, when the business environment was ...

  • Industries : Drug and Medication
  • Countries : United States
Romania Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Romania Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Following the resignation of Emil Boc and his government in February 2012, there is now considerable uncertainty with regard to reform of the Romanian healthcare segment . In particular, draft ...

  • Industries : Drug and Medication
  • Countries : Romania
Puerto Rico Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Puerto Rico Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Puerto Rico is struggling to retain its reputation as a pharmaceutical manufacturing hub, with a number of plants found to be in breach of regulations and standards over recent years. Additionally, ...

  • Industries : Drug and Medication
  • Countries : United States
Canada Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Canada Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: With Canada’s economy set to weather the external storm, the outlook for the country’s pharmaceutical industry looks relatively stable. Over the longer-term an ageing population in this ...

  • Industries : Drug and Medication
  • Countries : Canada
Estonia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Estonia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • March 2014
  • by Business Monitor International

BMI View: Estonia’s pharmaceutical industry will remain of marginal interest to multinationals given its small population and a modest growth outlook. We expect the industry to post a five-year compound ...

  • Industries : Drug and Medication
  • Countries : Estonia
Germany Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Germany Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Despite the threat of austerity measures and the government's focus on cost-containment within the pharmaceuticals and healthcare segment, as well as the impact of generic competition as a result ...

  • Industries : Drug and Medication
  • Countries : Germany
Hong Kong Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Hong Kong Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Despite an increasingly ageing population (consequently increasing burden of noncommunicable diseases) Hong Kong will only be moderately attractive to investors given its small industry size. ...

  • Industries : Pharmaceutical
  • Countries : United States, China
Lebanon Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Lebanon Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Continued improvement in Lebanon's intellectual property (IP) and pharmaceutical regulatory environment reinforces BMI's view that the country will begin to attract investment in a similar fashion ...

  • Industries : Drug and Medication
  • Countries : Lebanon
Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Slovenia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Slovenia's pharmaceutical industry outlook remains broadly unchanged in our Q212 assessment. While weak economic data and revised projections have led us to adjust our drug industry projections ...

  • Industries : Drug and Medication
  • Countries : Slovenia
Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Bulgaria Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Bulgaria’s pharmaceutical industry will be under some pressure in 2012 due to a weakening economic outlook and the tightening of publicly funded healthcare services. However, we have broadly ...

  • Industries : Generic Drug
  • Countries : Bulgaria
Taiwan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Taiwan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: While high volume consumption of pharmaceuticals per capita will continue to draw multinationals to Taiwan, the country remains committed to cost-containment in the public healthcare spending ...

  • Industries : Drug and Medication
  • Countries : Taiwan
Italy Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Italy Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: The pharmaceuticals and healthcare segment will be a target of further cost containment, particularly as National Health System (SSN) data for H111, which shows a decline in spending, highlights ...

  • Industries : Drug and Medication
  • Countries : Italy
Hungary Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Hungary Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Some changes have been made to the original March 2011 proposal to reduce costs in the pharmaceutical industry, representing moderately good news for drugmakers. However, this development will ...

  • Industries : Drug and Medication
  • Countries : Hungary
Oman Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Oman Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Oman’s 2012 budget allocated a greater sum of money to the healthcare segment, in line with BMI’s view that the Arab spring would lead to greater spending in this sector . The Omani government ...

  • Industries : Drug and Medication
  • Countries : Oman
Sweden Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Sweden Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Sweden’s high public expenditure on health (SEK252bn, or US Dollar 39bn, in 2011), accounting for 79% of total healthcare expenditure) is a major factor in making it an attractive place to ...

  • Industries : Drug and Medication
  • Countries : Sweden
Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Netherlands Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: While the Netherlands is a low risk industry from the point of view of multinational drugmakers, the country’s modest per capita expenditure on pharmaceuticals relative to other Western Europe ...

  • Industries : Drug and Medication
  • Countries : Netherlands
Turkey Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Turkey Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: While the Turkish pharmaceutical market has achieved some concessions following additional price cuts and public discounts announced in November 2011, the impact of the November decree remains ...

  • Industries : Drug and Medication
  • Countries : United States, Turkey
Jordan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Jordan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: The attractiveness of Jordan’s pharmaceutical and healthcare industry s in the short term will be shaped by the prevailing political and economic conditions. The perceived worsening of the ...

  • Industries : Drug and Medication
  • Countries : Jordan
Vietnam Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Vietnam Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Despite strong growth potential, the government’s protectionist policy of preventing foreignowned industry players from distributing their products and other regulatory inefficiencies will ...

  • Industries : Drug and Medication
  • Countries : Vietnam
Argentina Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Argentina Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Measured in local currency and in US dollars, the value of Argentina’s pharmaceutical industry is expected to grow at double-digit rates over the five years to 2016, in large part due to inflationary ...

  • Industries : Drug and Medication
  • Countries : Argentina
Uzbekistan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Uzbekistan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Uzbekistan’s pharmaceutical industry remains one of the fastest growing in the Central and Eastern Europe (CEE) region and its population and currently low levels of per capita pharmaceutical ...

  • Industries : Drug and Medication
  • Countries : Uzbekistan
Colombia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Colombia Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Colombia’s pharmaceutical and healthcare industry s will perform better than the regional average over the medium term due to its high urbanisation rate and population growth. Strong macroeconomic ...

  • Industries : Drug and Medication
  • Countries : Colombia
Japan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Japan Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Japan’s pharmaceutical industry is highly attractive to both foreign and local drugmakers. All three sub-sectors – patented, generic and over-the-counter (OTC) medicines – are large and ...

  • Industries : Drug and Medication
  • Countries : Japan
New Zealand Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

New Zealand Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: New Zealand has slipped ranks in our latest Risk/Reward Ratings – falling behind India due to the fact its small pharmaceutical industry is not as attractive as India’s industry for multinational ...

  • Industries : Drug and Medication
  • Countries : New Zealand
Central America Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Central America Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Central America’s pharmaceutical industry will experience moderate growth over the medium term, primarily due to the region’s underwhelming macroeconomic outlook. Increasing narcotics trafficking, ...

  • Industries : Pharmaceutical
  • Countries : North America, Costa Rica, Nicaragua, Guatemala, El Salvador, Panama, Honduras, Belize, World
Thailand Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

Thailand Pharmaceuticals and Healthcare Industry Update Quarter 2 2012

  • $ 1 300
  • Industry report
  • February 2014
  • by Business Monitor International

BMI View: Thailand is a moderately attractive pharmaceutical industry for multinationals. On the positive side, rewards are potentially considerable, given the country’s epidemiological profile and the ...

  • Industries : Drug and Medication
  • Countries : Thailand

» View Public Reports

About 41 000 reports

Global Clinical Trial : Innovation and Technology Trends

  • Industry report
  • April 2014
  • 16 pages

... Complexities, and so on). Within the cro market, the largest segment was that of drug discovery. Based on various analyses, the report also anticipates that the market for clinical data management services ...


» Read our Company Profiles

About 600 Companies

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Novartis Inc.

Switzerland

Pfizer Inc.

United States

GlaxoSmithKline PLC

United Kingdom

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.